• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient.利奈唑胺成功治疗腹膜透析患者耐万古霉素肠球菌腹膜炎且无需拔除导管
Perit Dial Int. 2014 Mar-Apr;34(2):235-9. doi: 10.3747/pdi.2013.00076.
2
Successful treatment of vancomycin-resistant enterococcal peritonitis with linezolid in a kidney transplant patient: a case report and review of the literature.利奈唑胺成功治疗肾移植患者耐万古霉素肠球菌腹膜炎：病例报告及文献复习
Perit Dial Int. 2004 Jan-Feb;24(1):70-2.
3
Linezolid disposition during peritonitis: a case report.利奈唑胺在腹膜炎期间的处置：一例病例报告。
Perit Dial Int. 2004 Jan-Feb;24(1):68-70.
4
[Treatment of vancomycin-resistant Enterococcus with linezolid in paediatric hospitals].
Farm Hosp. 2007 Jan-Feb;31(1):43-7. doi: 10.1016/s1130-6343(07)75710-0.
5
Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.利奈唑胺成功治疗一名合并人类免疫缺陷病毒感染的肾移植受者的耐万古霉素粪肠球菌心内膜炎。
Transpl Infect Dis. 2004 Sep;6(3):117-9. doi: 10.1111/j.1399-3062.2004.00059.x.
6
Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.耐利奈唑胺或中介利奈唑胺、耐万古霉素的屎肠球菌菌株发病率的增加与利奈唑胺使用量的增加同步。
Antimicrob Agents Chemother. 2008 Jun;52(6):2256-9. doi: 10.1128/AAC.00070-08. Epub 2008 Apr 7.
7
Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.利奈唑胺短程治疗耐万古霉素屎肠球菌脑膜炎
Int J Clin Pract. 2006 Jun;60(6):740-1. doi: 10.1111/j.1368-5031.2006.00706.x.
8
Linezolid for treatment of vancomycin-resistant enterococcal peritonitis.利奈唑胺用于治疗耐万古霉素肠球菌腹膜炎。
Am J Kidney Dis. 2001 Oct;38(4):E20. doi: 10.1053/ajkd.2001.27729.
9
Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.巴西一家医院中耐万古霉素粪肠球菌和屎肠球菌分离株对利奈唑胺的耐药性
Antimicrob Agents Chemother. 2014 May;58(5):2993-4. doi: 10.1128/AAC.02399-14. Epub 2014 Mar 10.
10
Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child.一名儿童耐万古霉素肠球菌性脑室炎的成功治疗
Braz J Infect Dis. 2007 Apr;11(2):297-9. doi: 10.1590/s1413-86702007000200027.

引用本文的文献

1
Peritoneal dialysis-related peritonitis: challenges and solutions.腹膜透析相关性腹膜炎：挑战与解决方案
Int J Nephrol Renovasc Dis. 2018 Jun 11;11:173-186. doi: 10.2147/IJNRD.S123618. eCollection 2018.
2
Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.用于治疗腹膜透析相关性腹膜炎的新型抗生素。
Clin Kidney J. 2016 Aug;9(4):616-23. doi: 10.1093/ckj/sfw059. Epub 2016 Jul 4.
3
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.国际腹膜透析学会腹膜炎推荐意见：2016年预防与治疗更新版
Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9.
4
The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.不同腹膜透析液对氨苄西林、达托霉素和利奈唑胺体外抗粪肠球菌活性的影响。
Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2257-63. doi: 10.1007/s10096-015-2477-8. Epub 2015 Sep 4.
5
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring.一名腹膜透析患者中与利奈唑胺相关的血液学毒性：治疗药物监测的作用
Eur J Clin Pharmacol. 2015 Mar;71(3):383-5. doi: 10.1007/s00228-015-1809-z. Epub 2015 Jan 22.

本文引用的文献

1
Antimicrobial resistance in Asia: current epidemiology and clinical implications.亚洲的抗菌药物耐药性：当前的流行病学及临床意义
Infect Chemother. 2013 Mar;45(1):22-31. doi: 10.3947/ic.2013.45.1.22. Epub 2013 Mar 29.
2
Successful use of intravenous linezolid in CAPD patient with vancomycin-resistant enterococcal peritonitis.静脉注射利奈唑胺成功用于治疗耐万古霉素肠球菌腹膜炎的持续性非卧床腹膜透析患者。
Perit Dial Int. 2011 Mar-Apr;31(2):209-10. doi: 10.3747/pdi.2010.00121.
3
Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.由耐万古霉素屎肠球菌引起的腹膜透析相关性腹膜炎。
Ther Apher Dial. 2011 Feb;15(1):115-6. doi: 10.1111/j.1744-9987.2010.00852.x. Epub 2010 Aug 31.
4
Vancomycin-resistant enterococci peritonitis development after shifting from hemodialysis to peritoneal dialysis.万古霉素耐药肠球菌性腹膜炎在血液透析转为腹膜透析后发生。
Ren Fail. 2010;32(9):1121-2. doi: 10.3109/0886022X.2010.509899.
5
Peritoneal dialysis-related infections recommendations: 2010 update.腹膜透析相关感染的建议：2010年更新版
Perit Dial Int. 2010 Jul-Aug;30(4):393-423. doi: 10.3747/pdi.2010.00049.
6
Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.腹腔内使用达托霉素成功治疗耐万古霉素肠球菌腹膜炎。
Am J Kidney Dis. 2009 Sep;54(3):538-41. doi: 10.1053/j.ajkd.2008.12.017. Epub 2009 Feb 23.
7
Improving outcome of CAPD: twenty-five years' experience in a single Korean center.改善持续性非卧床腹膜透析的治疗效果：韩国单一中心的25年经验
Perit Dial Int. 2007 Jul-Aug;27(4):432-40.
8
ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends.2004年的终末期肾病患者：患者数量、治疗方式及相关趋势的全球概述。
Nephrol Dial Transplant. 2005 Dec;20(12):2587-93. doi: 10.1093/ndt/gfi159. Epub 2005 Oct 4.
9
Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis.透析患者中耐万古霉素肠球菌定植的患病率及危险因素评估。
Am J Kidney Dis. 2004 Aug;44(2):337-43. doi: 10.1053/j.ajkd.2004.04.038.
10
Successful treatment of vancomycin-resistant enterococcal peritonitis with linezolid in a kidney transplant patient: a case report and review of the literature.利奈唑胺成功治疗肾移植患者耐万古霉素肠球菌腹膜炎：病例报告及文献复习
Perit Dial Int. 2004 Jan-Feb;24(1):70-2.

Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient.

作者信息

Song In Ji, Seo Ji Won, Kwon Young Eun, Kim Young Ly, Lim Tae Seop, Kang Ea Wha, Chang Tae Ik

机构信息

Department of Internal Medicine1 Yonsei University College of Medicine Seoul, Republic of Korea Department of Internal Medicine2 NHIS Medical Center Ilsan Hospital Goyangshi, Gyeonggi-do, Republic of Korea.

出版信息

Perit Dial Int. 2014 Mar-Apr;34(2):235-9. doi: 10.3747/pdi.2013.00076.

DOI:10.3747/pdi.2013.00076
PMID:24676744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3968111/
Abstract
摘要